98%
921
2 minutes
20
Hailey-Hailey disease (HHD) is a rare autosomal dominant genodermatosis. It is characterized clinically by recurrent erosions, blisters and erythematous plaques at the sites of friction and intertriginous areas. The pathogenic gene of HHD was reported to be the ATPase calcium-transporting type 2C member 1 gene (). In this study, genomic DNA polymerase chain reaction (PCR) and direct sequencing of were performed from 3 Chinese pedigrees and 4 sporadic cases of HHD. We detected 3 heterozygous mutations, including 2 novel mutations (c.1673_1674insGTTG and c.2225A>G) and 1 recurrent nonsense mutation (c.1402C>T; NM_014382.4). The gene was also screened in the asymptomatic members of pedigrees. Our results would further expand the mutation spectrum of the gene and be helpful in the genetic counseling of patients with HHD.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216019 | PMC |
http://dx.doi.org/10.1159/000514282 | DOI Listing |
Dermatol Ther (Heidelb)
September 2025
Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 9, 40138, Bologna, Bologna, Italy.
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have gained prominence for their efficacy in treating type 2 diabetes and obesity. Recent evidence suggests that their pleiotropic effects-beyond glycemic control and weight loss-include anti-inflammatory, immunomodulatory, and antioxidative effects, which may beneficially support various dermatologic conditions such as psoriasis, hidradenitis suppurativa, acanthosis nigricans, and Hailey-Hailey disease. However, GLP-1 RAs are also associated with emerging cutaneous adverse drug reactions, including bullous, exanthematous and vasculitic manifestations, and other rare side effects.
View Article and Find Full Text PDFJ Dermatol Sci
August 2025
Department of Dermatology, Maastricht University Medical Centre+, Maastricht Center of Expertise for Genodermatoses, Maastricht, the Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, the Netherlands; Department of Clinical Genetics, Maastricht University Medical Centre+,
Dermatol Surg
August 2025
Department of Dermatology, Tulane University, New Orleans, Louisiana.
Endocr J
August 2025
Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Okayama 701-0192, Japan.
Hailey-Hailey disease (HHD), or familial benign chronic pemphigus, is a rare autosomal dominant disorder characterized by recurrent vesicles and erosions in intertriginous areas. Topical corticosteroids are the primary treatment, but their potential systemic side effects are often overlooked. Prolonged use on compromised skin can lead to excessive absorption, increasing the risk of iatrogenic Cushing's syndrome and adrenal insufficiency.
View Article and Find Full Text PDFCureus
June 2025
Dermatology, Temple University Hospital, Philadelphia, USA.
Hailey-Hailey disease (HHD) is a rare autosomal dominant genodermatosis caused by mutations in the ATP2C1 gene, leading to impaired calcium homeostasis and epidermal acantholysis. Clinically, it manifests as recurrent, painful erosions in the intertriginous areas and is often resistant to conventional treatments, such as topical corticosteroids, antibiotics, and retinoids. This report describes the case of a 67-year-old woman with refractory HHD who presented with painful, pruritic erosions affecting the axillary, inguinal, and inframammary regions.
View Article and Find Full Text PDF